Nuzenio

For Arrowhead Pharmaceuticals

For Arrowhead Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Timeline

Wed, 05 Aug 2026 09:20:04 GMTArrowhead Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $110.2, Implies 23% Upside - TradingView
Wed, 05 Aug 2026 05:05:00 GMTArrowhead Pharmaceuticals Inc (ARWR) (Q3 2026) Earnings Call Highlights: Strong Phase III Data ... - Yahoo Finance
Wed, 05 Aug 2026 02:46:50 GMTArrowhead Pharmaceuticals Acquires FDA Priority Review Voucher - BioSpace
Wed, 05 Aug 2026 00:14:20 GMTArrowhead Pharmaceuticals (NASDAQ:ARWR) Announces Quarterly Earnings Results - MarketBeat
Tue, 04 Aug 2026 22:03:56 GMTArrowhead Pharmaceuticals Q3 Earnings Call Highlights - Yahoo Finance
Tue, 04 Aug 2026 21:11:19 GMTArrowhead Pharmaceuticals Reports Fiscal 2026 Third Quarter Results - Arrowhead Pharmaceuticals, Inc.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for For Arrowhead Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.